To describe clinical and molecular characteristics of an outbreak due to metallo-β-lactamases (MBLs) producing Klebsiella pneumoniae collected at Charles Nicolle Hospital of Tunis and to analyze the impact of outer membrane porin (OMP) loss on carbapenem resistance levels.
Methods:
Between 2010 and 2015, 178 carbapenem-resistant Enterobacteriaceae were isolated. Screening for MBL production was performed using combined disk diffusion method, with imipenem and ethylene diamine tetraacetic acid (EDTA) as inhibitors. Resistance genes and virulence factors were identified by polymerase chain reaction (PCR) and sequencing. Genotyping was performed by pulsed-field gel electrophoresis and multilocus sequence typing. Genetic environment of carbapenemase genes was determined by PCR mapping. Conjugation assays were performed, and plasmids were assigned to incompatibility groups by PCR-based replicon typing. OMPs were profiled by sodium dodecyl sulfate-polyacrilamide gel electrophoresis, and porin genes were sequenced.
Results:
Nineteen K. pneumoniae (10.6%) showing MBL activity were isolated from patients hospitalized on four different wards. NDM-1 was the only MBL identified, in association with blaOXA-48. All strains lacked at least one OMP, and carbapenem resistance levels were remarkably elevated in strains lacking OmpK35 and OmpK36. blaNDM-1 was located in IncFIA-type conjugative plasmid, with the same genetic context in all strains. The epidemiological diffusion of blaNDM-1 was due to two clones, one major clone belonging to sequence type (ST) 147 (n = 16) and the other clone belonging to ST307 (n = 3).
Conclusions:
This study describes an outbreak of NDM-1-producing K. pneumoniae strains, isolated from a Tunisian hospital, caused by two clones belonging to ST147 and ST307; and highlights the role of OMPs loss, in combination with β-lactamase expression, in conferring high carbapenem resistance.
Get full access to this article
View all access options for this article.
References
1.
PatelG., and BonomoR.A.. 2013. “Stormy waters ahead”: global emergence of carbapenemases. Front. Microbiol., 4:48.
2.
SekarU.2013. OXA-181 beta lactamase is not a major mediator of carbapenem resistance in Enterobacteriaceae. J. Clin. Diagn. Res., 7:1986–1988.
3.
PoirelL., DortetL., BernabeuS., and NordmannP.. 2011. Genetic features of blaNDM-1-positive Enterobacteriaceae. Antimicrob. Agents Chemother., 55:5403–5407.
4.
ZapunA., Contreras-MartelC., and VernetT.. 2008. Penicillin-binding proteins and beta-lactam resistance. FEMS Microbiol. Rev., 32:361–385.
5.
YongD., TolemanM.A., GiskeC.G., ChoH.S., SundmanK., LeeK., et al.2009. Characterization of a new metallo-β-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob. Agents Chemother., 53:5046–5054.
6.
LivermoreD.M., WalshT.R., TolemanM., and WoodfordN.. 2011. Balkan NDM-1: escape or transplant? Lancet Infect. Dis., 11:164.
7.
ShiblA., Al-AgamyM., MemishZ., SenokA., KhaderS.A., and AssiriA.. 2013. The emergence of OXA-48- and NDM-1-positive Klebsiella pneumoniae in Riyadh, Saudi Arabia. Int. J. Infect. Dis., 17:e1130–e1133.
8.
Ben NasrA., DecreD., CompainF., GenelN., BarguellilF., and ArletG.. 2013. Emergence of NDM-1 in association with OXA-48 in Klebsiella pneumoniae from Tunisia. Antimicrob. Agents Chemother., 57:4089–4090.
9.
IzdebskiR., BojarskaK., BaraniakA., LiterackaE., HerdaM., ŻabickaD., et al.2015. NDM-1- or OXA-48-producing Enterobacteriaceae colonising Polish tourists following a terrorist attack in Tunis, March 2015. Euro Surveill., 20:21150.
10.
MessaoudiA., HaenniM., MansourW., SarasE., Bel Haj KhalifaA., ChaouchC., et al.2017. ST147 NDM-1-producing Klebsiella pneumoniae spread in two Tunisian hospitals. J. Antimicrob. Chemother., 72:315–316.
11.
PotronA., PoirelL., RondinaudE., and NordmannP.. 2013. Intercontinental spread of OXA-48 beta-lactamase-producing Enterobacteriaceae over a 11-year period, 2001 to 2011. Euro Surveill., 18:20549.
12.
PeiranoG., PillaiD.R., Pitondo-SilvaA., RichardsonD., and PitoutJ.D.D.. 2011. The characteristics of NDM-producing Klebsiella pneumoniae from Canada. Diagn. Microbiol. Infect. Dis., 71:106–109.
13.
AbdelazizM.O., BonuraC., AleoA., El-DomanyR.A., FascianaT., and MamminaC.. 2012. OXA-163-producing Klebsiella pneumoniae in Cairo, Egypt, in 2009 and 2010. J. Clin. Microbiol., 50:2489–2491.
14.
BornetC., Davin-RegliA., BosiC., PagesJ.M., and BolletC.. 2000. Imipenem resistance of Enterobacter aerogenes mediated by outer membrane permeability. J. Clin. Microbiol., 38:1048–1052.
15.
BradfordP.A., UrbanC., MarianoN., ProjanS.J., RahalJ.J., and BushK.. 1997. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein. Antimicrob. Agents Chemother., 41:563–569.
16.
SaïdaniM., HammamiS., KammounA., SlimA., and Boutiba-Ben BoubakerI.. 2012. Emergence of carbapenem-resistant OXA-48 carbapenemase-producing Enterobacteriaceae in Tunisia. J. Med. Microbiol., 61:1746–1749.
GalaniI., RekatsinaP.D., HatzakiD., PlachourasD., SouliM., and GiamarellouH.. 2008. Evaluation of different laboratory tests for the detection of metallo-beta-lactamase production in Enterobacteriaceae. J. Antimicrob. Chemother., 61:548–553.
19.
Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Third Informational Supplement. CLSI Doc. M100-S23. Wayne, PA.
20.
DallenneC., Da CostaA., DecréD., FavierC., and ArletG.. 2010. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. J. Antimicrob. Chemother., 65:490–495.
21.
YooJ.S., KimH.M., KooH.S., YangJ.W., YooJ.I., KimH.S., et al.2013. Nosocomial transmission of NDM-1-producing Escherichia coli ST101 in a Korean hospital. J. Antimicrob. Chemother., 68:2170–2172.
22.
Fernández-MartínezM., MiróE., OrtegaA., BouG., González-LópezJ.J., OliverA., et al.2015. Molecular identification of aminoglycoside-modifying enzymes in clinical isolates of Escherichia coli resistant to amoxicillin/clavulanic acid isolated in Spain. Int. J. Antimicrob. Agents, 46:157–163.
23.
FerjaniS., SaidaniM., AmineF.S., and Boutiba-Ben BoubakerI.. 2015. Prevalence and characterization of plasmid-mediated quinolone resistance genes in extended-spectrum β-lactamase-producing Enterobacteriaceae in a Tunisian hospital. Microb. Drug Resist., 21:158–166.
24.
KimY.-T., JangJ.-H., KimH.-C., KimH., LeeK.-R., ParkK.S., et al.2011. Identification of strain harboring both aac(6′)-Ib and aac(6′)-Ib-cr variant simultaneously in Escherichia coli and Klebsiella pneumoniae. BMB Rep., 44:262–266.
25.
PoirelL., BonninR.A., and NordmannP.. 2012. Genetic features of the widespread plasmid coding for the carbapenemase OXA-48. Antimicrob. Agents Chemother., 56:559–562.
26.
Martínez-MartínezL., ConejoM.C., PascualA., Hernández-AllésS., BallestaS., Ramírez De Arellano-RamosE., et al.2000. Activities of imipenem and cephalosporins against clonally related strains of Escherichia coli hyperproducing chromosomal beta-lactamase and showing altered porin profiles. Antimicrob. Agents Chemother., 44:2534–2536.
27.
CarattoliA.2009. Resistance plasmid families in Enterobacteriaceae. Antimicrob. Agents Chemother., 53:2227–2238.
28.
ArletG., RouveauM., CasinI., BouvetP.J., LagrangeP.H., and PhilipponA.. 1994. Molecular epidemiology of Klebsiella pneumoniae strains that produce SHV-4 beta-lactamase and which were isolated in 14 French hospitals. J. Clin. Microbiol., 32:2553–2558.
29.
TenoverF.C., ArbeitR.D., GoeringR.V., MickelsenP.A., MurrayB.E., PersingD.H., et al.1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol., 33:2233–2239.
30.
DiancourtL., PassetV., VerhoefJ., GrimontP.A.D., and BrisseS.. 2005. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J. Clin. Microbiol., 43:4178–4182.
31.
CompainF., BabosanA., BrisseS., GenelN., AudoJ., AilloudF., et al.2014. Multiplex PCR for detection of seven virulence factors and K1/K2 capsular serotypes of Klebsiella pneumoniae. J. Clin. Microbiol., 52:4377–4380.
32.
YuW.-L., KoW.-C., ChengK.-C., LeeC.-C., LaiC.-C., and ChuangY.-C.. 2008. Comparison of prevalence of virulence factors for Klebsiella pneumoniae liver abscesses between isolates with capsular K1/K2 and non-K1/K2 serotypes. Diagn. Microbiol. Infect. Dis., 62:1–6.
33.
Martínez-MartínezL., PascualA., Conejo MdelC., GarcíaI., JoyanesP., Doménech-SánchezA., et al.2002. Energy-dependent accumulation of norfloxacin and porin expression in clinical isolates of Klebsiella pneumoniae and relationship to extended-spectrum beta-lactamase production. Antimicrob. Agents Chemother., 46:3926–3932.
34.
TenoverF.C., KalsiR.K., WilliamsP.P., CareyR.B., StockerS., LonswayD., et al.2006. Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing. Emerg. Infect. Dis., 12:1209–1213.
35.
RichterS.S., and MarchaimD.. 2017. Screening for carbapenem-resistant Enterobacteriaceae: who, when, and how? Virulence, 8:417–426.
36.
NordmannP., GniadkowskiM., GiskeC.G., PoirelL., WoodfordN., and MiriagouV.. 2012. Identification and screening of carbapenemase-producing Enterobacteriaceae. Clin. Microbiol. Infect., 18:432–438.
37.
NordmannP., NaasT., and PoirelL.. 2011. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg. Infect. Dis., 17:1791–1798.
38.
CastanheiraM., DeshpandeL.M., MathaiD., BellJ.M., JonesR.N., and MendesR.E.. 2011. Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006–2007. Antimicrob. Agents Chemother., 55:1274–1278.
39.
GiskeC.G., Martinez-MartinezL., StefaniS., GlupczynskiY., NordmannP., WoottonM., et al.2013. EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance. Basel, European Society of Clinical Microbiology and Infectious Diseases.
40.
Martínez-MartínezL., PascualA., Hernández-AllésS., Alvarez-DíazD., SuárezA.I., TranJ., et al.1999. Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae. Antimicrob. Agents Chemother., 43:1669–1673.
41.
DortetL., PoirelL., Al YaqoubiF., and NordmannP.. 2012. NDM-1, OXA-48 and OXA-181 carbapenemase-producing Enterobacteriaceae in Sultanate of Oman. Clin. Microbiol. Infect. Dis., 18:E144–E148.
42.
RimrangB., ChanawongA., LulitanondA., WilailuckanaC., CharoensriN., SribenjaluxP., et al.2012. Emergence of NDM-1- and IMP-14a-producing Enterobacteriaceae in Thailand. J. Antimicrob. Chemother., 67:2626–2630.
43.
TsaiY.-K., FungC.-P., LinJ.-C., ChenJ.-H., ChangF.-Y., ChenT.-L., et al.2011. Klebsiella pneumoniae outer membrane porins OmpK35 and OmpK36 play roles in both antimicrobial resistance and virulence. Antimicrob. Agents Chemother., 55:1485–1493.
44.
CleggS., and MurphyC.N.. 2016. Epidemiology and virulence of Klebsiella pneumoniae.Microbiol. Spectr., 4: UTI-0005-2012.
45.
XieL., DouY., ZhouK., ChenY., HanL., GuoX., et al.2017. Coexistence of blaOXA-48 and truncated blaNDM-1 on different plasmids in a Klebsiella pneumoniae Isolate in China. Front. Microbiol., 8:133.
